Category: Defective Products

DePuy Hip Implant Litigation Growing

The DePuy Hip Implant litigation continues to grow. In December 2010, the court approved a multidistrict litigation (MDL) for the cases filed in federal court. State class actions cases have been filed in Ohio and California.  In August 2010, Depuy recalled 93,000 hip implants.  The hip implants have a higher failure rate than other hip replacement devices. One out of eight patients has had to undergo a second hip replacement surgery due to the defective implant. Besides the high failure rate, the device also may cause elevated levels of cobalt and chromium in the body which can develop into metallosis – a buildup of metallic debris in soft tissues. It is believed that the metal on metal design of the hip implant is causing the metallosis.

Read More

Graco Stroller Recall

Graco Stroller Recall 2010 – Newell Rubbermaid’s Graco has announced today that they will be voluntarily recalling over 2 million Graco Quattro Tour and MetroLite strollers after the company discovered that 4 babies were killed between between 2003 and 2005.

According to the Consumer Product Safety Commission, the well known baby product manufacturer is pulling the devices of the shelves because it was revealed that infants can accidentally get strapped inside the strollers and be strangled to death.
The baby product company further explained that when kids are not seated and strapped properly into the strollers, they are able to slide through the opening located between the stroller tray and bottom of the seat, where they can get trapped, suffer mild to life threading injuries or be strangled.

The contraption that are being recalled are the Graco Quattro Tour and MetroLite strollers and travel systems with the following codes 8755, 8324, 4600, 8740, 8994, 8676 and 8910.

The hazardous products were available for purchase in 50 states between November 2000 and December 2007.

Read More

DePuy Recalls 93,000 ASR Hip Implants

In late August, 2010, DePuy Orthapedics, a unit of Johnson & Johnson, announced they were recalling two kinds of hip implants. The Food and Drug Administration had received consumer complaints about the hip implants for the last two years. Since 2008, there have been nearly 400 complaints of device failure.

The hip implant failure resulted in patients needing second painful surgeries to replace the first defective hip implant device. It is estimated that around 93,000 people have received the defective hip implant worldwide.

The two recalled DePuy hip implants are the ASR XL Acetabular System, a hip socket replacement and the ASR Hip Resurfacing System, which is a partial hip replacement and puts a metal cap on the ball of the femur. The Acetabular System has been sold all over the world and the resurfacing system has been in use in countries outside of the US.

The ASR hip implants are part of a larger group of medical devices known as metal-on-metal bearings. These devices have known problems generating debris from wear. Some patients develop tissue damage and inflammation as a result.

Last March, the British agency that regulates medical devices issued an advisory about the ASR problems. DePuy began warning doctors about high failure rates in the hip implant the same month the British advisory came out. Prior to this, DePuy claimed they were phasing out the hip implant device due to slow sales.

Failure rates as high as 12 and 13 percent within five years of the patient receiving the medical device were measured. Some doctors and orthopedic experts have expressed dismay that the hip implants were not recalled sooner.

If you or a loved one have been injured as a result of a DePuy hip implant, you should contact our attorneys today.

Read More

FDA Warning On Yaz

In October of 2008, the FDA issued a warning letter to Yaz notifying the birth control manufacturer that two of its commercials made deceptive claims.

The ads in question included a commercial in which women were seen releasing balloons labeled with symptoms of PMS as “Good Bye to You” played in the background. The second commercial cited in the FDA warning letter is one that featured women punching, kicking and pushing balloons, which were also labeled with PMS symptoms, while the song “We’re not gonna take it” played.

In the warning letter, the FDA pointed to two specific claims made in the Yaz commercials that constituted deceptive advertising. First, the FDA said the ads implied that Yaz helps lessen or eliminate the symptoms of PMS when in fact the birth control is only intended as treatment for PMDD.

Second, said the FDA, the ads gave the impression that Yaz treats acne of all severity levels when, in actuality, it is only approved for the treatment of moderate acne.

In 2009, 27 state attorneys general joined together to file a Yaz false advertising lawsuit against Bayer HealthCare Pharmaceuticals, the maker of Yaz. As part of the lawsuit settlement, Yaz agreed to run a new ad to correct the misleading information contained in the offending two commercials.

Yaz is potentially more dangerous to women than other contraceptives due to specific ingredients contained in the Yaz pill. These two deceptive ads encouraged women to take Yaz for purposes other than birth control. Because Yaz became increasingly popular as a treatment for acne and PMS, more women were exposed to the risk of the pill’s life-threatening side effects.  If you have been injured by Yaz, please call our lawyers today.

Read More

Seriously Injured By Yaz Oral Contraceptive – Contact Our CT Lawyers

Yaz and Yasmin are oral contraceptives taken for pregnancy prevention. Many women who have taken Yaz and Yasmin have suffered severe and life-threatening side effects. Tragically, some women have even died from taking Yaz and Yasmin.

 

Side effects of Yasmin and Yaz include:

 

  • Stroke
  • Heart attack
  • Blood clots
  • Pulmonary embolism
  • Gallbladder damage
  • Deep vein thrombosis
  • Death

Yaz and Yasmin are more dangerous than other oral contraceptives because they both contain drospirenone. Drospirenone is a diuretic that can drastically increase a woman’s potassium levels. Significantly increased potassium levels can lead to both blood clots and gallbladder damage.

 

Women who have been injured as a result of taking Yaz or Yasmin birth control are eligible to bring a Yaz lawsuit and seek compensation for their losses. Contact our Connecticut Yaz injury lawyers.

Read More